Developing cellular therapies for retinal degenerative diseases.
about
A novel immunodeficient NOD.SCID-rd1 mouse model of retinitis pigmentosa to investigate potential therapeutics and pathogenesis of retinal degenerationROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures.Photosensitivity of neurons enabled by cell-targeted gold nanoparticles.Cellular models and therapies for age-related macular degeneration.Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.Allogenic iPSC-derived RPE cell transplants induce immune response in pigs: a pilot study.Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment EpitheliumResponses of Multipotent Retinal Stem Cells to IL-1β, IL-18, or IL-17Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's MembraneLet There Be Light: Gene and Cell Therapy for Blindness.Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modelingFeatures specific to retinal pigment epithelium cells derived from three-dimensional human embryonic stem cell cultures - a new donor for cell therapy.A basis for comparison: sensitive authentication of stem cell derived RPE using physiological responses of intact RPE monolayers.Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.Poly(trimethylene carbonate) as an elastic biodegradable film for human embryonic stem cell-derived retinal pigment epithelial cells.Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models.Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model.TGF-β2 secretion from RPE decreases with polarization and becomes apically oriented.Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study.Human umbilical tissue-derived cells rescue retinal pigment epithelium dysfunction in retinal degeneration.Human ESC-derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration.Stem Cell Treatment in Retinal Diseases: Recent Developments.Translational strategies and challenges in regenerative medicine.Production de rétinesin vitroà partir de cellules pluripotentes humaines
P2860
Q33588022-AADA2CEA-C08B-4B50-A21E-D6AB457CA016Q34109426-D4BC581F-C9B7-403C-902F-112ED84B7E07Q34763667-291B8E83-A5C4-445F-AD19-BB623567894CQ35365344-90BFAFAD-0244-4504-B920-B17A1BA781E6Q35558042-7C506F1D-4ADF-4892-94B0-26C3F092A15CQ35608700-686C4439-27C2-42BA-A37C-6AC190085308Q35797607-C4695316-587A-48AF-9D6A-AA1DD484480CQ35813401-BFEF9D7B-5E3F-4A5A-9D65-DA780D1E0607Q35852620-2592A2F4-DE23-428C-A4B3-117E857D7CDFQ36173100-B2CBEC98-4BCC-4E18-88E0-2C1C31A4D8E2Q36630592-C5DA8AD3-67DC-47E0-A9A3-4C61660E3E6AQ36654534-9753FBDB-0FF4-447A-9886-24E4F5B4915AQ36813794-AF28F9C5-6388-4043-9BCD-721B378FD6FDQ37225683-D20587C3-5F2B-4FF6-AFE4-ADB1ADF7A9C9Q37686695-E27801D0-C790-4B67-B0D9-1661B1E3F1E6Q38391372-44357680-91C1-4AE2-9B0A-F57B5ECAEA60Q38766799-FD3DCA78-79F0-422B-88B2-E2CBF553DE5DQ39040799-75069A5D-7E73-40F7-A705-07A7F838E653Q41447715-4F9C5DF3-5858-4F10-98F5-4AAB27701DDEQ42126622-34E104BA-0051-4516-822B-B213D9E81415Q42161396-F23B7079-DB5D-46F2-84D2-BBA2F6A62C50Q42317934-23A0FC81-E6D6-468D-AA99-AFEE25259690Q46651920-E52031B2-6CBC-47F1-BB08-E91C72B04869Q48374271-5E631B01-457D-4A7E-8999-C22C475DE7AFQ52632524-2A9F0E9C-D51F-4ACD-BF00-B20433E683E2Q53479362-9FAC9FE0-F540-4834-B91B-7934FCC32DB6Q58222792-04419A9F-CDEB-48D7-B9A9-E0B34BACFBA9
P2860
Developing cellular therapies for retinal degenerative diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Developing cellular therapies for retinal degenerative diseases.
@ast
Developing cellular therapies for retinal degenerative diseases.
@en
type
label
Developing cellular therapies for retinal degenerative diseases.
@ast
Developing cellular therapies for retinal degenerative diseases.
@en
prefLabel
Developing cellular therapies for retinal degenerative diseases.
@ast
Developing cellular therapies for retinal degenerative diseases.
@en
P2093
P2860
P356
P1476
Developing cellular therapies for retinal degenerative diseases.
@en
P2093
Brian P Brooks
Christene A Huang
David Stroncek
Ellen Feigal
Jan C van Meurs
Kapil Bharti
Mahendra Rao
Sara Chandros Hull
Sheldon S Miller
P2860
P304
P356
10.1167/IOVS.13-13481
P407
P577
2014-02-26T00:00:00Z